HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Technical Hurdles, Commercial Limits Complicate Supplement-To-Drug Moves

This article was originally published in The Tan Sheet

Executive Summary

Firms should investigate regulatory hurdles and gauge the commercial appeal of a finished product before moving dietary supplement ingredients into the pharmaceutical realm, say manufacturing and testing consultants

You may also be interested in...



FDA Guidance Raises Prospect Of More INDs For Supplement Research

An FDA draft guidance that seeks to clarify when an investigational new drug application should be filed may add logistical knots to the process of studying foods and dietary ingredients, stakeholders say.

Supplement-To-Drug Applications Look Like The Next Wave To Some Experts

FDA's dietary supplement good manufacturing practices, while imposed to help assure safe nutritionals reach the market, are creating costs that could drive more firms to file new drug applications for natural products, according to a pair of regulatory experts

GOED Casts Wider Membership Net As Omega-3 Applications Broaden

The Global Organization for EPA and DHA Omega-3s expands its board of directors as the increasing use of fish oil across the food and drug industries spurs membership growth

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134672

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel